Among @ patients eligible for haemodynamic analysis ( serelaxin , n = @ ; placebo , n = @ ) , those treated with serelaxin had a significantly higher decrease in peak PCWP during the first @ h of infusion ( difference vs. placebo : -@ mmHg , P = @ ) .